Tapewire

Nasdaq · USD

NKTR

NEKTAR THERAPEUTICS

Export transactions ↓
Tapewire entity
4364
SEC CIK
0000906709
Parsed reports
471

Last 12 months

Inside the activity.

0 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202500
Jan 202601
Feb 202602
Mar 202600
Apr 202600
May 202602
Jun 202606
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 19, 2017 Filed Sep 21, 2017 21:02 UTC GrantCommon Stock 9,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-053626 · doc4.xml · nonDerivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.

F3 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 21:02 UTC GrantCommon Stock 13,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-053626 · doc4.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,500

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.

F2 · deemedExecutionDate: This restricted stock unit award vests over three years in equal annual installments beginning on September 19, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:57 UTC GrantStock Option · Derivative 22,500 $0.00 Strike: $21.75 $0.00
Disclosure

SEC source: 0001209191-17-053625 · doc4.xml · derivative · entry 3

WINGER DENNIS L · CIK 0001222645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: common stock · 22,500 shares

Expires 2025-09-18

F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:57 UTC GrantCommon Stock 9,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-053625 · doc4.xml · nonDerivative · entry 1

WINGER DENNIS L · CIK 0001222645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,250

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:56 UTC GrantStock Option · Derivative 22,500 $0.00 Strike: $21.75 $0.00
Disclosure

SEC source: 0001209191-17-053623 · doc4.xml · derivative · entry 2

KUEBLER CHRISTOPHER A · CIK 0001229877 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: common stock · 22,500 shares

Expires 2025-09-18

F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:56 UTC GrantCommon Stock 9,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-053623 · doc4.xml · nonDerivative · entry 1

KUEBLER CHRISTOPHER A · CIK 0001229877 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,500

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:51 UTC GrantStock Option · Derivative 22,500 $0.00 Strike: $21.75 $0.00
Disclosure

SEC source: 0001209191-17-053618 · doc4.xml · derivative · entry 3

WHITFIELD ROY A · CIK 0000936728 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: common stock · 22,500 shares

Expires 2025-09-18

F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:51 UTC GrantCommon Stock 9,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-053618 · doc4.xml · nonDerivative · entry 1

WHITFIELD ROY A · CIK 0000936728 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,000

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:49 UTC
Lingnau LutzDirector
GrantStock Option · Derivative 22,500 $0.00 Strike: $21.75 $0.00
Disclosure

SEC source: 0001209191-17-053617 · doc4.xml · derivative · entry 2

Lingnau Lutz · CIK 0001354179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: common stock · 22,500 shares

Expires 2025-09-18

F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:49 UTC
Lingnau LutzDirector
GrantCommon Stock 9,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-053617 · doc4.xml · nonDerivative · entry 1

Lingnau Lutz · CIK 0001354179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,450

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:46 UTC GrantStock Option · Derivative 22,500 $0.00 Strike: $21.75 $0.00
Disclosure

SEC source: 0001209191-17-053615 · doc4.xml · derivative · entry 2

Krivulka Joseph J · CIK 0001296750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: common stock · 22,500 shares

Expires 2025-09-18

F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:46 UTC GrantCommon Stock 9,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-053615 · doc4.xml · nonDerivative · entry 1

Krivulka Joseph J · CIK 0001296750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,000

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:43 UTC GrantStock Option · Derivative 22,500 $0.00 Strike: $21.75 $0.00
Disclosure

SEC source: 0001209191-17-053613 · doc4.xml · derivative · entry 2

GREER R SCOTT · CIK 0001211703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: common stock · 22,500 shares

Expires 2025-09-18

F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:43 UTC GrantCommon Stock 9,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-053613 · doc4.xml · nonDerivative · entry 1

GREER R SCOTT · CIK 0001211703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,333

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:40 UTC
CHESS ROBERTDirector
GrantStock Option · Derivative 22,500 $0.00 Strike: $21.75 $0.00
Disclosure

SEC source: 0001209191-17-053611 · doc4.xml · derivative · entry 2

CHESS ROBERT · CIK 0001227886 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: common stock · 22,500 shares

Expires 2025-09-18

F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 20:40 UTC
CHESS ROBERTDirector
GrantCommon Stock 9,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-053611 · doc4.xml · nonDerivative · entry 1

CHESS ROBERT · CIK 0001227886 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,623

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017.

Read SEC document
September 06, 2017 Filed Sep 8, 2017 22:08 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionStock Option · Derivative 83,333 $0.00 Strike: $11.34 $0.00
Disclosure

SEC source: 0001209191-17-052127 · doc4.xml · derivative · entry 4

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333,333

Underlying: Common Stock · 83,333 shares

Expires 2018-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin on March 9, 2017 related to 500,000 stock options scheduled to expire on January 31, 2018.

Read SEC document
September 06, 2017 Filed Sep 8, 2017 22:08 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 83,333 $21.54 $1,794,992.82
Disclosure

SEC source: 0001209191-17-052127 · doc4.xml · nonDerivative · entry 2

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,504

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin on March 9, 2017 related to 500,000 stock options scheduled to expire on January 31, 2018.

F2 · price: This transaction was executed in multiple trades at prices ranging from $21.09 to $21.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
September 06, 2017 Filed Sep 8, 2017 22:08 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock 83,333 $11.34 $944,996.22
Disclosure

SEC source: 0001209191-17-052127 · doc4.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,837

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin on March 9, 2017 related to 500,000 stock options scheduled to expire on January 31, 2018.

Read SEC document
August 16, 2017 Filed Aug 18, 2017 23:05 UTC
Thomsen Jillian B.SVP & Chief Accounting Officer
SaleCommon Stock 2,648 $19.32 $51,159.36
Disclosure

SEC source: 0001209191-17-049669 · doc4.xml · nonDerivative · entry 1

Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,838

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F3 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 3,250 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
August 16, 2017 Filed Aug 18, 2017 23:05 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionStock Option · Derivative 83,334 $0.00 Strike: $11.34 $0.00
Disclosure

SEC source: 0001209191-17-049668 · doc4.xml · derivative · entry 5

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,666

Underlying: Common Stock · 83,334 shares

Expires 2018-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin on March 9, 2017 related to 500,000 stock options scheduled to expire on January 31, 2018.

Read SEC document
August 16, 2017 Filed Aug 18, 2017 23:05 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 83,334 $19.25 $1,604,179.50
Disclosure

SEC source: 0001209191-17-049668 · doc4.xml · nonDerivative · entry 3

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,504

F3 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin on March 9, 2017 related to 500,000 stock options scheduled to expire on January 31, 2018.

F4 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
August 16, 2017 Filed Aug 18, 2017 23:05 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock 83,334 $11.34 $945,007.56
Disclosure

SEC source: 0001209191-17-049668 · doc4.xml · nonDerivative · entry 2

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin on March 9, 2017 related to 500,000 stock options scheduled to expire on January 31, 2018.

Read SEC document
August 16, 2017 Filed Aug 18, 2017 23:05 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 8,380 $19.32 $161,901.60
Disclosure

SEC source: 0001209191-17-049668 · doc4.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,504

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
August 16, 2017 Filed Aug 18, 2017 23:04 UTC
Nicholson JohnSVP & Chief Operating Officer
SaleCommon Stock 3,177 $19.32 $61,379.64
Disclosure

SEC source: 0001209191-17-049667 · doc4.xml · nonDerivative · entry 1

Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 224,066

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
August 16, 2017 Filed Aug 18, 2017 23:04 UTC
Labrucherie Gil MSVP & Chief Financial Officer
SaleCommon Stock 3,177 $19.32 $61,379.64
Disclosure

SEC source: 0001209191-17-049666 · doc4.xml · nonDerivative · entry 1

Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,414

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F3 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 3,250 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
August 16, 2017 Filed Aug 18, 2017 23:03 UTC
Hora ManinderSVP Pharma Dev & Mfg Ops
SaleCommon Stock 2,956 $19.32 $57,109.92
Disclosure

SEC source: 0001209191-17-049665 · doc4.xml · nonDerivative · entry 1

Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,233

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F3 · balance_after: This number includes 6,000 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c).

Read SEC document
August 16, 2017 Filed Aug 18, 2017 23:02 UTC
Gergel Ivan P.SVP & Chief Medical Officer
SaleCommon Stock 1,997 $19.32 $38,582.04
Disclosure

SEC source: 0001209191-17-049664 · doc4.xml · nonDerivative · entry 1

Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,575

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
August 16, 2017 Filed Aug 18, 2017 23:01 UTC
Doberstein Stephen KSVP & Chief Scientific Officer
SaleCommon Stock 1,701 $19.32 $32,863.32
Disclosure

SEC source: 0001209191-17-049663 · doc4.xml · nonDerivative · entry 1

Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,102

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
August 10, 2017 Filed Aug 14, 2017 13:07 UTC PurchaseCommon Stock 35,000 $17.95 $628,250.00
Disclosure

SEC source: 0001209191-17-048678 · doc4.xml · nonDerivative · entry 1

WHITFIELD ROY A · CIK 0000936728 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,000

F1 · price: This transaction was executed in multiple trades at prices ranging from $17.89 to $17.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
July 18, 2017 Filed Jul 20, 2017 21:08 UTC
Gergel Ivan P.SVP & Chief Medical Officer
Exercise / conversionStock Option · Derivative 54,920 $0.00 Strike: $11.04 $0.00
Disclosure

SEC source: 0001209191-17-045842 · doc4.xml · derivative · entry 3

Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 413,752

Underlying: Common Stock · 54,920 shares

Expires 2022-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
July 18, 2017 Filed Jul 20, 2017 21:08 UTC
Gergel Ivan P.SVP & Chief Medical Officer
SaleCommon Stock 54,920 $21.10 $1,158,812.00
Disclosure

SEC source: 0001209191-17-045842 · doc4.xml · nonDerivative · entry 2

Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,572

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $21.04 to $21.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
July 18, 2017 Filed Jul 20, 2017 21:08 UTC
Gergel Ivan P.SVP & Chief Medical Officer
Exercise / conversionCommon Stock 54,920 $11.04 $606,316.80
Disclosure

SEC source: 0001209191-17-045842 · doc4.xml · nonDerivative · entry 1

Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
July 14, 2017 Filed Jul 19, 2017 00:02 UTC
Lingnau LutzDirector
Exercise / conversionStock Option · Derivative 30,000 $0.00 Strike: $14.26 $0.00
Disclosure

SEC source: 0001209191-17-045609 · doc4.xml · derivative · entry 3

Lingnau Lutz · CIK 0001354179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2018-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
July 14, 2017 Filed Jul 19, 2017 00:02 UTC
Lingnau LutzDirector
SaleCommon Stock 30,000 $20.76 $622,800.00
Disclosure

SEC source: 0001209191-17-045609 · doc4.xml · nonDerivative · entry 2

Lingnau Lutz · CIK 0001354179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,450

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.40 to $20.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
July 14, 2017 Filed Jul 19, 2017 00:02 UTC
Lingnau LutzDirector
Exercise / conversionCommon Stock 30,000 $14.26 $427,800.00
Disclosure

SEC source: 0001209191-17-045609 · doc4.xml · nonDerivative · entry 1

Lingnau Lutz · CIK 0001354179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,450

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
July 12, 2017 Filed Jul 14, 2017 00:01 UTC
Gergel Ivan P.SVP & Chief Medical Officer
Exercise / conversionStock Option · Derivative 36,691 $0.00 Strike: $11.04 $0.00
Disclosure

SEC source: 0001209191-17-045121 · doc4.xml · derivative · entry 6

Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 468,672

Underlying: Common Stock · 36,691 shares

Expires 2022-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
July 12, 2017 Filed Jul 14, 2017 00:01 UTC
Gergel Ivan P.SVP & Chief Medical Officer
SaleCommon Stock 36,691 $21.09 $773,813.19
Disclosure

SEC source: 0001209191-17-045121 · doc4.xml · nonDerivative · entry 4

Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,572

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $21.04 to $21.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
July 12, 2017 Filed Jul 14, 2017 00:01 UTC
Gergel Ivan P.SVP & Chief Medical Officer
Exercise / conversionCommon Stock 36,691 $11.04 $405,068.64
Disclosure

SEC source: 0001209191-17-045121 · doc4.xml · nonDerivative · entry 3

Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,263

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
July 11, 2017 Filed Jul 14, 2017 00:01 UTC
Gergel Ivan P.SVP & Chief Medical Officer
Exercise / conversionStock Option · Derivative 8,389 $0.00 Strike: $11.04 $0.00
Disclosure

SEC source: 0001209191-17-045121 · doc4.xml · derivative · entry 5

Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 505,363

Underlying: Common Stock · 8,389 shares

Expires 2022-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
July 11, 2017 Filed Jul 14, 2017 00:01 UTC
Gergel Ivan P.SVP & Chief Medical Officer
SaleCommon Stock 8,389 $21.04 $176,504.56
Disclosure

SEC source: 0001209191-17-045121 · doc4.xml · nonDerivative · entry 2

Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,572

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $21.04 to $21.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
July 11, 2017 Filed Jul 14, 2017 00:01 UTC
Gergel Ivan P.SVP & Chief Medical Officer
Exercise / conversionCommon Stock 8,389 $11.04 $92,614.56
Disclosure

SEC source: 0001209191-17-045121 · doc4.xml · nonDerivative · entry 1

Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,961

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
June 26, 2017 Filed Jun 28, 2017 22:05 UTC Exercise / conversionStock Option · Derivative 15,000 $0.00 Strike: $8.37 $0.00
Disclosure

SEC source: 0001209191-17-042168 · doc4.xml · derivative · entry 2

Krivulka Joseph J · CIK 0001296750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2017-09-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 26, 2017 Filed Jun 28, 2017 22:05 UTC Exercise / conversionCommon Stock 15,000 $8.37 $125,550.00
Disclosure

SEC source: 0001209191-17-042168 · doc4.xml · nonDerivative · entry 1

Krivulka Joseph J · CIK 0001296750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 07, 2017 Filed Jun 9, 2017 22:02 UTC
Nicholson JohnSVP & Chief Operating Officer
Exercise / conversionStock Option · Derivative 150,000 $0.00 Strike: $6.34 $0.00
Disclosure

SEC source: 0001209191-17-038973 · doc4.xml · derivative · entry 3

Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 150,000 shares

Expires 2017-06-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on June 9, 2017.

Read SEC document
June 07, 2017 Filed Jun 9, 2017 22:02 UTC
Nicholson JohnSVP & Chief Operating Officer
SaleCommon Stock 101,700 $19.24 $1,956,708.00
Disclosure

SEC source: 0001209191-17-038973 · doc4.xml · nonDerivative · entry 2

Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,243

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on June 9, 2017.

F2 · price: This transaction was executed in multiple trades at prices ranging from $18.83 to $19.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
June 07, 2017 Filed Jun 9, 2017 22:02 UTC
Nicholson JohnSVP & Chief Operating Officer
Exercise / conversionCommon Stock 150,000 $6.34 $951,000.00
Disclosure

SEC source: 0001209191-17-038973 · doc4.xml · nonDerivative · entry 1

Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,943

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on June 9, 2017.

Read SEC document
May 16, 2017 Filed May 19, 2017 00:50 UTC
Thomsen Jillian B.SVP & Chief Accounting Officer
SaleCommon Stock 2,651 $19.55 $51,827.05
Disclosure

SEC source: 0001209191-17-033772 · doc4.xml · nonDerivative · entry 1

Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,986

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.31 to $19.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F3 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
May 16, 2017 Filed May 19, 2017 00:50 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 8,388 $19.55 $163,985.40
Disclosure

SEC source: 0001209191-17-033771 · doc4.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,884

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.31 to $19.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
May 16, 2017 Filed May 19, 2017 00:49 UTC
Nicholson JohnSVP & Chief Operating Officer
SaleCommon Stock 3,146 $19.55 $61,504.30
Disclosure

SEC source: 0001209191-17-033770 · doc4.xml · nonDerivative · entry 1

Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,943

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.31 to $19.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.